Compass Financial Advisors LLC Dexcom Inc Transaction History

Compass Financial Advisors LLC

  • $0
  • Q3 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023
SELL
$104.0 - $122.92 $91,520 - $108,169
-880 Reduced 10.81%
7,257 $843,000
Q4 2022

Feb 06, 2023
SELL
$84.98 - $122.67 $23,029 - $33,243
-271 Reduced 3.22%
8,137 $921,000
Q2 2022

Aug 08, 2022
BUY
$67.99 - $132.89 $433,436 - $847,173
6,375 Added 313.58%
8,408 $627,000
Q1 2022

May 05, 2022
BUY
$94.08 - $130.2 $23,614 - $32,680
251 Added 14.09%
2,033 $1.04 Million
Q4 2021

Feb 24, 2022
BUY
$129.87 - $162.82 $231,428 - $290,145
1,782 New
1,782 $957,000

Others Institutions Holding DXCM

# of Institutions
1,014
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Compass Financial Advisors LLC Portfolio

Follow Compass Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compass Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Compass Financial Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email